Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
The REMAP-CAP study is looking at the best ways to treat adults who are very unwell with lung infections such as severe pneumonia, the flu, or COVID-19, and need care in an intensive care unit (ICU). It's a special type of study that allows doctors to test many different treatments at the same time to see which ones are most effective. This flexible design means the study can quickly adapt to new information, helping doctors make better decisions about care. The goal is to improve how patients recover from these serious illnesses. This study can also quickly adapt to new health crises, like a pandemic, to find treatments for new viruses.
De un vistazo
¿De qué trata este estudio?
When someone is very ill with a serious lung infection, like severe pneumonia, the flu, or COVID-19, they often need to be looked after in an intensive care unit (ICU). In the ICU, doctors use many different treatments to help patients get better and fight off the infection. While doctors know many treatments are helpful, it's not always clear which combination works best for different people.
This study, called REMAP-CAP, is designed to help doctors figure out the most effective ways to treat these severe lung infections. It's a clever type of study that can test many different treatments all at once. What's more, it's 'adaptive', meaning it can learn from the patients already in the study. This helps the study identify promising treatments faster and direct new patients towards the treatments that seem to be working best.
The main aim is to improve how patients recover from these serious lung infections. It also acts like a flexible research 'platform' that can quickly start looking for treatments if a new widespread illness, like a pandemic, emerges. This means it can rapidly respond to new health challenges and continue to find the best care for patients.
Puntos clave
- Targets severe lung infections like pneumonia, flu, and COVID-19.
- Aims to find the best combinations of existing treatments.
- Can test many treatments at once and adapt quickly.
- Helps improve care for very unwell patients in intensive care.
- Can rapidly respond to new health crises, like pandemics.
¿Quién puede ser elegible?
Generally, to join the main REMAP-CAP study, you need to be an adult (18 or over) admitted to an intensive care unit (ICU) because of a severe lung infection, like pneumonia, within two days of getting to the hospital. Your doctors would have seen signs of a lung infection and scans showing changes in your lungs. You would also need support for your organs, such as help with breathing or medication to support your blood pressure.
¿Podría este estudio ser adecuado para ti?
Responde estas preguntas rápidas para ver si puedes ser elegible. Esto es solo una guía: el equipo de investigación toma la decisión final.
- ¿Tienes 18 años o más?
- Have you been admitted to intensive care for a severe lung infection?
- Did you come to the ICU within 48 hours of being admitted to the hospital?
- Do you need support for breathing or blood pressure in the ICU?
¿En qué consiste la participación?
If you are asked to join this study, it means your doctors believe you could benefit from it. You would continue to receive the best care for your condition, and the study would involve trying different combinations of existing treatments. This includes various medicines for infection, inflammation, or to prevent blood clots. There are no extra hospital visits or special appointments as part of the study; all monitoring would happen as part of your usual intensive care. The study aims to understand the best treatment approaches and would continue for as long as you need intensive care, with doctors monitoring your progress carefully.
Riesgos y beneficios potenciales
Locations (408)
- Universidad de FloridaCódigo postal verificadoJacksonville, Estados Unidos· Reclutamiento
- Augusta UniversityCódigo postal verificadoAugusta, United States· Aún no reclutando
- University of Illinois HealthCódigo postal verificadoChicago, Estados Unidos· Reclutamiento
- Tulane Medical CenterCódigo postal verificadoNew Orleans, United States· Aún no reclutando
- University of MichiganCódigo postal verificadoAnn Arbor, Estados Unidos· Reclutamiento
- Memorial Sloan Kettering Cancer CenterCódigo postal verificadoNueva York, Estados Unidos· Reclutamiento
- Wake Forest Baptist HealthCódigo postal verificadoWinston-Salem, United States· Aún no reclutando
- The Ohio State University Wexner Medical CenterCódigo postal verificadoColumbus, Estados Unidos· Reclutamiento
- Oregon Health and Science UniversityCódigo postal verificadoPortland, Estados Unidos· Reclutamiento
- University of Pittsburgh Medical CentreCódigo postal verificadoPittsburgh, Estados Unidos· Reclutamiento
- Brown University - Rhode Island HospitalCódigo postal verificadoProvidence, United States· Aún no reclutando
- Canberra HospitalCódigo postal verificadoCanberra, Australia· Reclutamiento
Preguntas comunes
What kind of infections does this study look at?
It looks at serious lung infections like pneumonia, the flu, and severe COVID-19 that require intensive care.
Why is this study different from others?
It can test many treatments at once and adapt quickly, learning from patients already in the study to find better treatments faster.
¿Recibiré un trato especial si me uno?
You will receive the best possible care, and the study helps doctors choose the most effective combination of existing treatments for you.
¿Tendré que pagar por algo?
No, all care and treatments related to the study are part of your hospital care and involve no extra cost to you.
¿Puedo abandonar el estudio si cambio de opinión?
Yes, you or your family can decide to withdraw from the study at any time. Your medical care will not be affected.
Cómo obtener más información
Cameron Green, MSc
Siempre hable con su médico de cabecera o especialista antes de decidir participar en un estudio.
¿Interesado en participar?
Discusión
Discusión comunitaria
Impulsado por nuestro foro en community.patient.info. Por favor, sea respetuoso — esto no es un consejo médico.